Internal Medicine, Medical Oncology · Dallas, TX
NPI
1851437909
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5323 Harry Hines Blvd
Dallas, TX, 75390
Phone (214) 645-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
351 services
Medicare patients, 2024
124
Average age 72
Drug cost, 2024
$7.0M
676 prescriptions
Company payments, 2025
$5,397
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hans J Hammers was code 99215 (office e&m - established), 193 times for 69 patients. In total Hans J Hammers billed 351 services in 5 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 193 | 69 | $112.26 | $22K |
| 99215 Office E&M - Established | Office | 122 | 73 | $118.95 | $15K |
| 99205 Office E&M - New | Facility | 26 | 26 | $129.37 | $3,364 |
By year: 2022 $54K for 642 services; 2023 $33K for 308 services; 2024 $41K for 351 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hans J Hammers prescribed most often to Medicare patients was Inlyta (Axitinib), with 103 prescriptions and refills. In total Hans J Hammers wrote 676 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Inlyta Axitinib | 103 | 103 | 11 | $2.0M |
| Cabometyx Cabozantinib S-Malate | 74 | 74 | 20 | $1.8M |
| Levothyroxine Sodium Generic | 69 | 143 | 16 | $807 |
| Welireg Belzutifan | 69 | 69 | 11 | $1.9M |
| Eliquis Apixaban | 59 | 59 | 11 | $34K |
| Lenvima Lenvatinib Mesylate | 34 | 34 | Under 11 | $783K |
| Pantoprazole Sodium Generic | 30 | 60 | Under 11 | $271 |
| Prochlorperazine Maleate Generic | 24 | 24 | Under 11 | $301 |
| Prednisone Generic | 22 | 25 | 14 | $70.35 |
| Gabapentin Generic | 21 | 23 | Under 11 | $133 |
| Lorazepam Generic | 13 | 13 | Under 11 | $16.24 |
| Fotivda Tivozanib Hcl | 13 | 13 | Under 11 | $388K |
| Ondansetron Hcl Generic | 13 | 16 | Under 11 | $197 |
| Amlodipine Besylate Generic | 12 | 20 | Under 11 | $23.37 |
| Triamcinolone Acetonide Generic | 11 | 11 | Under 11 | $110 |
Brand drugs: 372 claims; generic drugs: - claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hans J Hammers $5,397 ($5,397 in general payments such as food, travel and fees) from 8 companies. The largest payer was Eisai Inc. with $5,078.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.